Basket trial health technology assessment requirements and limited access to innovations in oncology: The French paradox
- 1 January 2022
- journal article
- letter
- Published by Elsevier in European Journal of Cancer
- Vol. 162, 128-129
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Basket clinical trial design for targeted therapies for cancer: a French National Authority for Health statement for health technology assessmentThe Lancet Oncology, 2021
- Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 studyThe Lancet Oncology, 2020
- PD-1 Blockade in Tumors with Mismatch-Repair DeficiencyNew England Journal of Medicine, 2015